Stay updated with breaking news from Director Corazon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Get Free Report) traded up 8.6% on Wednesday . The stock traded as high as $45.09 and last traded at $44.97. 711,930 shares traded hands during mid-day trading, a decline of 5% from the average session volume of 751,268 shares. The stock had previously closed at $41.40. Wall […]
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Get Free Report) traded up 8.6% on Wednesday . The stock traded as high as $45.09 and last traded at $44.97. 711,930 shares traded hands during mid-day trading, a decline of 5% from the average session volume of 751,268 shares. The stock had previously closed at $41.40. Wall […]
Avidity Partners Management LP grew its holdings in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 55.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 844,500 shares of the biopharmaceutical company’s stock after acquiring an additional 300,500 shares during the period. […]
Avidity Partners Management LP grew its holdings in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 55.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 844,500 shares of the biopharmaceutical company’s stock after acquiring an additional 300,500 shares during the period. […]
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Get Free Report)’s share price rose 4.2% during mid-day trading on Tuesday . The company traded as high as $38.41 and last traded at $38.22. Approximately 300,437 shares were traded during mid-day trading, a decline of 51% from the average daily volume of 611,562 shares. The stock had previously closed […]